Dysfunctional high-density lipoprotein: an updated review
Frontiers in Cardiovascular Medicine · 16.12.2025 · 12
DOI: 10.3389/fcvm.2025.1713387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 16.12.2025. Verfasst von Frances W Ouyang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cardiology Research Laboratories, Vascular and Medicinal Research, The Texas Heart Institute at Baylor College of Medicine, Houston, TX, Un…. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
High-density lipoprotein (HDL) has earned its reputation as “good” cholesterol in cardiovascular health, primarily because of its strong inverse association with cardiovascular disease. A potential mechanism for this association is its ability to promote cholesterol efflux capacity (CEC) and consequently reduce the buildup of cholesterol in arterial plaque. However, recent research underscores the importance of not only maintaining high HDL cholesterol (HDL-C) levels but also ensuring the functionality and quality of HDL particles. HDL particles exhibit various other atheroprotective activities, including anti-inflammatory, antioxidant, and vasodilatory properties. Collectively, these functions are thought to contribute to reducing cardiovascular risk beyond mere cholesterol transport. Both acute and chronic inflammation can induce structural and functional changes in HDL, potentially rendering the particles pro-inflammatory. Factors that increase inflammation, such as lifestyle choices, autoimmune diseases, and oxidative stress, can adversely affect HDL functionality. Dysfunctional HDL, such as electronegative HDL H5 or HDL isolated from patients with cardiovascular disease (CVD), may lose its protective properties and even contribute to CVD progression by promoting inflammation, oxidative stress, and endothelial damage. Recent studies indicate that the CEC of HDL particles may serve as a more critical determinant of atheroprotection than the absolute concentration of HDL-C. This review emphasizes the need to focus on both quantity and quality of HDL to reduce cardiovascular risk more effectively. Understanding the mechanisms behind HDL's protective effects provide valuable insights into heart health and potential therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Cardiology Research Laboratories, Vascular and Medicinal Research, The Texas Heart Institute at Baylor College of Medicine, Houston, TX, United States.
- National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan.
- Department of Child Care, College of Humanities and Social Sciences, National Pingtung University of Science and Technology, Pingtung, Taiwan.
- Division of Cardiology, Department of Internal Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan.
- Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
Zitieren
APA
Ouyang, F. W., Chiang, H. H., Hsu, W. L., Tsai, M. H., Huang, C. Y., Remaley, A. T., Akyol, O., & Chen, C. H. (2025). Dysfunctional high-density lipoprotein: an updated review. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1713387
Vancouver
Ouyang FW, Chiang HH, Hsu WL, Tsai MH, Huang CY, Remaley AT, et al. Dysfunctional high-density lipoprotein: an updated review. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1713387
BibTeX
@article{Ouyang2025,
author = {Ouyang, Frances W and Chiang, Huan-Hsing and Hsu, Wen-Li and Tsai, Ming-Hsien and Huang, Chun-Yao and Remaley, Alan T and Akyol, Omer and Chen, Chu-Huang},
title = {Dysfunctional high-density lipoprotein: an updated review},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1713387}
}
EUVIMED